Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Bartram Richard
 2. Date of Event Requiring Statement (Month/Day/Year)
12/14/2017		 3. Issuer Name and Ticker or Trading Symbol
Esperion Therapeutics, Inc. [ESPR]
(Last)
(First)
(Middle)
C/O ESPERION THERAPEUTICS, INC., 3891 RANCHERO DRIVE, SUITE 150		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Financial Officer
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

ANN ARBOR, MI 48108		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 1,200
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy)   (1) 04/24/2018 Common Stock 17,892 $ 3.7 D  
Stock Option (right to buy)   (1) 07/23/2023 Common Stock 15,000 $ 17.11 D  
Stock Option (right to buy)   (2) 12/20/2023 Common Stock 17,200 $ 12.92 D  
Stock Option (right to buy)   (3) 01/02/2025 Common Stock 30,000 $ 41.23 D  
Stock Option (right to buy)   (4) 03/18/2025 Common Stock 12,000 $ 105.72 D  
Stock Option (right to buy)   (5) 01/04/2026 Common Stock 25,000 $ 21.65 D  
Stock Option (right to buy)   (6) 01/03/2027 Common Stock 30,000 $ 12.88 D  
Stock Option (right to buy)   (7) 02/21/2027 Common Stock 6,500 $ 24.42 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Bartram Richard
C/O ESPERION THERAPEUTICS, INC.
3891 RANCHERO DRIVE, SUITE 150
ANN ARBOR, MI 48108		       Chief Financial Officer  

Signatures

Richard B. Bartram 12/14/2017
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) The options are fully vested as of the date hereof.
(2) The options vest over a four (4) year period. 25% of the shares vested on December 20, 2014, and an additional 1/16th vests on each quarterly anniversary of such date thereafter.
(3) The options vest over a four (4) year period in equal quarterly installments, the first of which was on April 2, 2015.
(4) The options vest over a four (4) year period in equal quarterly installments, the first of which was on June 18, 2015.
(5) The options vest over a four (4) year period in equal quarterly installments, the first of which was on April 4, 2016.
(6) The options vest over a four (4) year period in equal quarterly installments, the first of which was on April 3, 2017.
(7) The options vest over a four (4) year period in equal quarterly installments, the first of which was on May 21, 2017.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.